×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [7]
复旦大学上海医学院 [5]
西安交通大学 [4]
合肥物质科学研究院 [4]
中国医学科学院 北京... [3]
中南大学 [2]
更多...
内容类型
期刊论文 [34]
会议论文 [1]
发表日期
2021 [1]
2020 [2]
2019 [3]
2018 [7]
2017 [5]
2016 [3]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共35条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma
期刊论文
CANCER RADIOTHERAPIE, 2021, 卷号: 25
作者:
Zeng, J.
;
Cui, X.
;
Cheng, L.
;
Chen, Y.
;
Du, X.
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2021/08/31
Esophageal squamous cell carcinoma
Liposome-paclitaxel
Chemoradiotherapy
Toxicities
A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:
Fang, Jun
;
Wang, Yuezhen
;
Wang, Zhun
;
Xie, Tieming
;
Yan, Fengqin
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2020/11/26
Nanomicelle
miR-34a
esophageal carcinoma (EC)
p53
SIRT1
drug resistance
Late-course accelerated Hyperfractionation vs. Conventional Fraction Radiotherapy under precise technology plus Concurrent Chemotherapy for Esophageal Squamous Cell Carcinoma: comparison of efficacy and side effects
期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11, 期号: 10, 页码: 3020-3026
作者:
Luo, Hongtao
;
Wei, Shihong
;
Wang, Xiaohu
;
Liu, Ruifeng
;
Zhang, Qiuning
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/01/18
Esophageal cancer
late course accelerated hyperfractionation
Intensity-modulated radiotherapy
Image-guided radiotherapy
concurrent chemoradiotherapy
Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma
期刊论文
ONCOLOGY RESEARCH AND TREATMENT, 2019, 卷号: 42, 期号: 3
作者:
Sun, Si
;
Yu, Hui
;
Wang, Huijie
;
Zhang, Hai
;
Wu, Xianghua
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2019/12/05
Esophageal cancer
Chemotherapy
Metastatic
Squamous cell cancer, SCC
CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer
期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11, 页码: 3253-3264
作者:
Wang, Jiansong
;
Che, Wencheng
;
Wang, Weimin
;
Su, Gongzhang
;
Zhen, Tianchang
收藏
  |  
浏览/下载:108/0
  |  
提交时间:2019/12/11
esophageal cancer
chemoresistance
CDKN3
RAD51
DNA damage repair
ASO Author Reflections: Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma
期刊论文
Annals of Surgical Oncology, 2019
作者:
Wang X.
;
Liu X.
;
Li B.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo
期刊论文
MOLECULAR CANCER THERAPEUTICS, 2018, 卷号: 17, 期号: 7, 页码: 1540-1553
作者:
Song, Mengqiu
;
Liu, Xuejiao
;
Liu, Kangdong
;
Zhao, Ran
;
Huang, Hai
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2019/01/08
Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma
期刊论文
CELLULAR ONCOLOGY, 2018, 卷号: 41, 期号: 6
作者:
Sun, Xuan
;
Martin, Robert C. G.
;
Zheng, Qianqian
;
Farmer, Russell
;
Pandit, Harshul
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
EpCAM
Esophageal adenocarcinoma
Barrett's Esophagus
Adriamycin
Cisplatin
5-FU
Cancer stem cell
Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma
期刊论文
CANCER LETTERS, 2018, 卷号: 418
作者:
Sun, Yulin
;
Zhai, Linhui
;
Ma, Shouzhi
;
Zhang, Chengpu
;
Zhao, Lina
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
RIP3
Chemosensitivity
DNA repair
iTRAQ
HSP90/CDC37 complex
With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis
期刊论文
RADIOTHERAPY AND ONCOLOGY, 2018, 卷号: 129, 期号: 1
作者:
Chen, Yongshun
;
Guo, Liying
;
Cheng, Xinyu
;
Wang, Jun
;
Zhang, Yougai
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
Esophageal cancer
Locally advanced disease
Consolidation chemotherapy
Prognosis
©版权所有 ©2017 CSpace - Powered by
CSpace